U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06992232) titled 'Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC' on May 19.
Brief Summary: This multi-center randomized controlled phase II trial was carried out in several hospitals in China to evaluate the efficacy and safety of radiotherapy or radical prostatectomy combined with intense androgen deprivation therapy for newly diagnosed metastatic prostate cancer.
Study Start Date: Aug. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer Metastatic Disease
Intervention:
DRUG: Intense androgen deprivation therapy
Patients received ADT plus second-generation ARi (enzalutamide, apalutamide, darolu...